Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer.
CONCLUSION: Changes in mid-treatment PET-volumetric parameters were significantly associated with survival in NSCLC. A greater reduction in the mid-treatment MTV was associated with worse survival in patients treated with standard radiation, but with better survival in patients who received mid-treatment PET-adapted treatment.
PMID: 30389239 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Kong FS, Li L, Wang W, Campbell J, Waller JL, Piert M, Gross M, Cheng M, Owen D, Stenmark M, Huang KC, Frey KA, Ten Haken RK, Lawrence TS Tags: Radiother Oncol Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | Legislation | Lung Cancer | Non-Small Cell Lung Cancer | PET Scan | Radiology | Science | Study